Clinical Trial Update: Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and immune response of an H5N1 influenza vaccine in people previously vaccinated against H5N1 or H7N3 and in those never v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza H5n1

Drugs mentioned

• H5N1 influenza vaccine (influenza vaccine H5N1)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: H5N1 Influenza | Phase 1 | Status: COMPLETED